ANTON CHERRY: Open Payments
NPI 1730418757 · WALLINGFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,127 in 43 payments from 14 companies in 2025. Trend: 2023 $1,196 · 2024 $1,268 · 2025 $1,127
Food & beverage: $1,127
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $244 |
| Boston Scientific Corporation | 3 | $200 |
| Collegium Pharmaceutical, Inc. | 9 | $148 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $118 |
| SPR Therapeutics, Inc | 2 | $108 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $60 |
| SCILEX PHARMACEUTICALS INC. | 2 | $48 |
| Valinor Pharma, LLC | 2 | $44 |
| SI-BONE, INC. | 1 | $32 |
| Ipsen Biopharmaceuticals, Inc | 1 | $30 |
Products named: General - Pain Management, UBRELVY, Belbuca, RELISTOR, SPRINT PNS System, JOURNAVX, BOTOX, ZTLido.
Industry payments across CT — which companies pay providers there.
